Molecular Pharming Market in the North America is Expected to Register the Highest Share in Revenue Shortly – Says InsightAce Analytic

JERSEY CITY, N.J., June 21, 2024 /PRNewswire/ — InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on theGlobal Molecular Pharming Market Size, Share & Trends Analysis Report By Crop Source (Maize, Barley, Tobacco, Safflower, Rice, Alfalfa), By Technology (Gene Gun, Agroinfiltration, Electroporation, Agrobacterium-Mediated Gene Transfer), By Application (Recombinant Antibodies, Hormones, Vaccines, Industrial Enzymes, Proteins & Protein-Based Materials, Technical Reagents, Nutritional Products), By End User (Biotechnology & Pharmaceutical Companies, Contract Manufacturing Organizations)- Market Outlook And Industry Analysis 2031″

InsightAce Analytic Logo

The Global Molecular Pharming Market is valued at US$ 457.7 Mn in 2023, and it is expected to reach US$ 1,399.8 Mn by 2031, with a CAGR of 15.3% during the forecast period of 2024-2031.

Download Free Sample and ToC of the Report: 

Molecular pharming refers to biologics production in plant systems to reduce the cost of microbial systems. Molecular farming is an innovative method for producing molecular medicines, including plasma proteins, enzymes, growth factors, vaccinations, and recombinant antibodies. These medicines have widely accepted medicinal uses at a molecular level. The approach has the potential to change the pharmaceutical industry by providing highly efficient and cost-effective treatments to all segments of the population. Plant-based protein expression offers practical, secure, efficient, and cost-effective advantages.

Molecular pharming has the potential to offer a new platform for the development and delivery of vaccines and therapeutics for infectious diseases, particularly in low-resource environments. It can also contribute to improving human health and well-being by generating proteins that can regulate various physiological functions, including growth, metabolism, reproduction, and immunity.

By encouraging innovation, collaboration, and diversification, molecular pharming can also generate novel opportunities for the biotechnology sector and the entrepreneurial landscape. It can potentially facilitate the creation of innovative products and services that can directly address unmet medical requirements and market demands. The global molecular pharmaceutical industry will rise rapidly due to the expansion of studies into producing pharmaceuticals from plants and products. The sudden demand for precision medicine and its production from natural and organic sources will contribute to the market’s growth during the next five years.

List of Prominent Players in the Molecular Pharming Market:

  • Leaf Expression Systems
  • ORF Genetics hf.
  • Agrenvec S.L.
  • PlantForm
  • Protalix Biotherapeutics
  • Kbio, Inc.
  • Cape Biologix Technologies (Cape Bio Pharms)
  • Bright Biotech
  • Moolec Science SA
  • Miruku
  • Tiamat Sciences Corp.
  • IngredientWerks
  • Core Biogenesis
  • Diamante Società Benefit S.r.l.
  • Elo Life Systems
  • G+FLAS Life Sciences, Inc.
  • Finally Foods
  • Tiamat Sciences
  • POLOPO Ltd.
  • newmoo Foods
  • BionFarming GmbH

Molecular Pharming Market Report Scope:

Report Attribute


Market Size Value In 2023

USD 457.7 Mn

Market Size Value In 2031

USD 1.399.8 Mn

Growth rate CAGR

CAGR of 15.3% from 2023 to 2031

Quantitative units

Representation of revenue in US$ Mn, and CAGR from 2024 to 2031

Historic Year

2019 to 2023

Forecast Year


Report coverage

The forecast of revenue, the position of the company, the competitive market statistics, growth prospects, and trends

Segments covered

By Crop Type, Technology, Applications and End Users

Regional scope

North America; Europe; Asia Pacific; Latin America; Middle East & Africa

Country scope

U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; China; Japan; India; South Korea; Southeast Asia; South Korea; Southeast Asia

Order 180 Pages Full Report @

Market Dynamics:


The rising need for biologics to target complicated illnesses and decrease side effects compared to traditional small-molecule medications will drive market expansion, and molecular pharming offers a viable option to address this demand by providing a cost-effective and scalable technology for biologic production.

Furthermore, increased investment in R&D activities related to molecular pharming, growing awareness of its benefits, and advancements in gene editing technologies that allow for precise modification of host organisms for higher yields and improved product quality drive its adoption, resulting in market growth. Moreover, Numerous partnerships have been formed between industry and non-industry groups to develop plant-based treatments. The global market for molecular pharming is anticipated to expand at a healthy rate due to factors such as the rising prevalence of disease indications, rising demand for biologics, ongoing efforts to advance the development of such products, and further optimization of the related technologies.


Several issues, including depletion of natural resources and environmental degradation, restrict crop production. Furthermore, a lack of public awareness restricts the market’s growth.

Regional Trends:

The North American molecular pharming market is expected to register a considerable market share in revenue. It is projected to grow at a high CAGR shortly area is a pioneer in implementing new technologies. The region’s market has a high revenue due to factors including expanding government efforts that boost the implementation of modern agriculture technologies and established infrastructure. Besides, Asia Pacific has a substantial share in the molecular pharming market in emerging nations like India, China, and Australia. Numerous government projects are being carried out to promote contemporary precision agricultural technologies, increasing production.

Curious about this latest version of the report? @

Recent Developments:

  • In October 2023, Moolec Science, involved in development of animal proteins using plants through molecular pharming, raised $30M in cash and kind from investors via convertible notes. The company intends to focus on additional meat molecules and proteins in a variety of R&D initiatives. Instead of isolating and purifying the animal protein from sources, the company intends to offer soy and pea proteins with the meat proteins integrated in the matrix.
  • In Sep 2023, BioBetter, a FoodTech startup, launched its first food-grade pilot facility in northern Israel to expedite production of growth factors for cultivated meat. Using tobacco plants as self-sustained bioreactors, they aim to produce 100kg daily, scaling up to 5 tons by 2025, lowering costs for the industry.
  • In Nov 2022, Bright Biotech completed a financing round of $3.2 million. With this funding, the company is planning to invest in research and development for a novel genetic engineering technology to produce growth factors, increase its staff of prominent scientists, and scale up its manufacturing processes. The technique of the company extracts valuable proteins from the chloroplasts of plants, which can allow grown meat companies to reach affordable industrial manufacturing.

Segmentation of Molecular Pharming Market-

By Crop Source:

  • Maize
  • Barley
  • Tobacco
  • Safflower
  • Rice
  • Alfalfa

By Technology:

  • Gene Gun
  • Agroinfiltration
  • Electroporation
  • Agrobacterium-Mediated Gene Transfer
  • Others

By Application:

  • Recombinant Antibodies
  • Hormones
  • Vaccines
  • Industrial Enzymes
  • Proteins & Protein-Based Materials
  • Technical Reagents
  • Nutritional Products
  • Others

By End User:

  • Biotechnology & Pharmaceutical Companies
  • Contract Manufacturing Organizations
  • Others

By Region-

North America

  • The US
  • Canada
  • Mexico


  • Germany
  • The UK
  • France
  • Italy
  • Spain
  • Rest of Europe


  • China
  • Japan
  • India
  • South Korea
  • South East Asia
  • Rest of Asia Pacific

Latin America

  • Brazil
  • Argentina
  • Rest of Latin America

 Middle East & Africa

  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa

For More Customization @

Why should buy this report:

  • To receive a comprehensive analysis of the prospects for global Molecular Pharming market
  • To receive industry overview and future trends of global Molecular Pharming market
  • To analyze the Molecular Pharming market drivers and challenges
  • To get information on the Molecular Pharming market size value (US$ Mn) forecast till 2031
  • Major Investments, Mergers & Acquisition in global Molecular Pharming industry

Other Related Reports Published by InsightAce Analytic:

Plant-Based Vaccines Market

Plant-based Expression Systems Market

Plant Genetic Engineering Market

Plant Based API Market

Check Our Satisfied Clients Portfolio @

About Us:

InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

Contact Us:
InsightAce Analytic PVT. LTD
Tel.: +1 551 226 6109
Email: [email protected]
Follow us on LinkedIn: 



Cision View original content:—says-insightace-analytic-302178880.html